Acasti Pharma Future Growth
Future criteria checks 2/6
Acasti Pharma is forecast to grow earnings and revenue by 45.3% and 65% per annum respectively while EPS is expected to grow by 47.6% per annum.
Key information
45.3%
Earnings growth rate
47.6%
EPS growth rate
| Pharmaceuticals earnings growth | 23.6% |
| Revenue growth rate | 65.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 14 Aug 2024 |
Recent future growth updates
Recent updates
Will Acasti Pharma (NASDAQ:ACST) Spend Its Cash Wisely?
Sep 02
We're Keeping An Eye On Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate
Apr 20Will Acasti Pharma (NASDAQ:ACST) Spend Its Cash Wisely?
Nov 14We're Not Very Worried About Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate
May 10Acasti Pharma GAAP EPS of -$0.10
Aug 11Acasti inks deal for Grace Therapeutics, shares surge
May 07Acasti Pharma issues clarification on trading activity
Dec 23Acasti Pharma EPS in-line
Nov 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 19 | -20 | N/A | N/A | 1 |
| 3/31/2026 | 0 | -16 | -19 | -19 | 2 |
| 3/31/2025 | N/A | -17 | -17 | -17 | 2 |
| 6/30/2024 | N/A | -11 | -10 | -10 | N/A |
| 3/31/2024 | N/A | -13 | -12 | -12 | N/A |
| 12/31/2023 | N/A | -39 | -14 | -14 | N/A |
| 9/30/2023 | N/A | -40 | -15 | -15 | N/A |
| 6/30/2023 | N/A | -42 | -17 | -17 | N/A |
| 3/31/2023 | N/A | -42 | -16 | -16 | N/A |
| 12/31/2022 | N/A | -17 | -16 | -16 | N/A |
| 9/30/2022 | N/A | -17 | -17 | -17 | N/A |
| 6/30/2022 | N/A | -11 | -19 | -19 | N/A |
| 3/31/2022 | N/A | -10 | -17 | -17 | N/A |
| 12/31/2021 | 0 | -12 | -16 | -16 | N/A |
| 9/30/2021 | 0 | -11 | -15 | -15 | N/A |
| 6/30/2021 | 0 | -18 | -14 | -14 | N/A |
| 3/31/2021 | 0 | -20 | -14 | -14 | N/A |
| 12/31/2020 | 0 | 3 | -16 | -15 | N/A |
| 9/30/2020 | N/A | -6 | -19 | -18 | N/A |
| 6/30/2020 | N/A | -21 | -21 | -20 | N/A |
| 3/31/2020 | N/A | -26 | -23 | -23 | N/A |
| 12/31/2019 | N/A | -56 | -29 | -29 | N/A |
| 9/30/2019 | N/A | -46 | -29 | -29 | N/A |
| 6/30/2019 | N/A | -42 | -27 | -27 | N/A |
| 3/31/2019 | N/A | -39 | -25 | -25 | N/A |
| 12/31/2018 | N/A | -31 | -20 | -19 | N/A |
| 9/30/2018 | N/A | -34 | -17 | -16 | N/A |
| 6/30/2018 | N/A | -20 | -13 | -13 | N/A |
| 3/31/2018 | N/A | -17 | N/A | -10 | N/A |
| 3/31/2017 | N/A | -8 | N/A | -5 | N/A |
| 11/30/2016 | 0 | -7 | N/A | -5 | N/A |
| 8/31/2016 | 0 | -7 | N/A | -5 | N/A |
| 5/31/2016 | 0 | -6 | N/A | -6 | N/A |
| 2/29/2016 | N/A | -5 | N/A | -5 | N/A |
| 11/30/2015 | 0 | -5 | N/A | -6 | N/A |
| 8/31/2015 | 0 | -1 | N/A | -6 | N/A |
| 5/31/2015 | 0 | -3 | N/A | -6 | N/A |
| 2/28/2015 | N/A | -1 | N/A | -6 | N/A |
| 11/30/2014 | 0 | -2 | N/A | -8 | N/A |
| 8/31/2014 | 0 | -8 | N/A | -7 | N/A |
| 5/31/2014 | 1 | -8 | N/A | -6 | N/A |
| 2/28/2014 | 0 | -10 | N/A | -6 | N/A |
| 11/30/2013 | 0 | -10 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ACST is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: ACST is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: ACST is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: ACST's revenue (65% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: ACST's revenue (65% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if ACST's Return on Equity is forecast to be high in 3 years time